
GC62423
GSK-3/CDK5/CDK2-IN-1
Also known as N-[1-(3-acetamidocyclobutyl)imidazol-4-yl]-2-naphthalen-2-ylacetamide
GSK-3/CDK5/CDK2-IN-1, an imidazole derivative, is an inhibitor of cdk5, cdk2, and GSK-3 extracted from patent WO2002010141A1, example 9a
ChemicalCAS395074-72-3MW362.42FormulaC21H22N4O2
- CAS number
- 395074-72-3
- Molecular weight
- 362.42
- Formula
- C21H22N4O2
- Solubility
- DMSO : 100 mg/mL (275·92 mM; Need ultrasonic)
- InChIKey
- XJRCZTVFSOVAQW-UHFFFAOYSA-N
- Catalogue number
- GC62423
- Brand
- GLPBIO
Computed properties PubChem CID 10155554 · XLogP 2.2 · TPSA 76 Ų · H-bond donors 2
- XLogP
- 2.2
- TPSA
- 76 Ų
- H-bond donors
- 2
- H-bond acceptors
- 3
- Rotatable bonds
- 5
- Heavy atoms
- 27
SMILES CC(=O)NC1CC(C1)N2C=C(N=C2)NC(=O)CC3=CC4=CC=CC=C4C=C3
Computed descriptors from PubChem (CID 10155554), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il